Cohance Lifesciences Limited Cohance Lifesciences Limited

Cohance Lifesciences Limited

COHANCE

Rang in aandelen #6369
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aandeelprijs
$5.05
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$1.93B
Verandering (1 dag)
-1.44%
Verandering (1 jaar)
-57.38%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)

Categorie

Healthcare
Dividendgeschiedenis van Cohance Lifesciences Limited (COHANCE)
Cohance Lifesciences Limited (aandelsymbool: COHANCE) heeft in totaal 5 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: $10.00
Dividendrendement (TTM): 0
Dividendbetalingen voor Cohance Lifesciences Limited (COHANCE) van 2021 tot 2026
Jaarlijkse dividendbetalingen
Jaar Dividend (aangepast voor aandelensplitsingen) Wijzigen
2026 (TTM) $5.00 -37.50%
2022 $8.00 300.00%
2021 $2.00 0.00%
Lijst van alle dividendbetalingen
Jaar Dividend Wijzigen
2026 (TTM) $5.00 -37.50%
2022 $8.00 300.00%
2021 $2.00 0.00%
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten